Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast cancer survivors

Kaufmann, Tara; Chang, Patrick; M. Rosenberg, Shoshana; S. Frank, Elizabeth; P. Hobbs, Brian; J. Bayne, Lauren; Nivar, Isoris; L. Goodspeed, Brooke; Rohn, Killian; M. Kugler, Emily; R. Fox, Kevin; M. Domchek, Susan; R. Bradbury, Angela; D. Shah, Payal; Knollman, Hayley; C. Jankowitz, Rachel; Makhlin, Igor; S. Clark, Amy; A. Chodosh, Lewis; DeMichele, Angela; Goodfellow, Katherine

doi:10.1158/1538-7445.sabcs22-p5-08-01

Public

Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast cancer survivors

Published in Cancer Research • Mar 1, 2023

Authors:

Tara Kaufmann

Patrick Chang

Shoshana M. Rosenberg

Abstract

Abstract Background: Patients treated for early stage breast cancer (BC) have a 30% lifetime risk of developing metastatic disease. Numerous studies have demonstrated that dormant bone marrow disseminated tumor cells (DTCs) are independently associated with risk of recurrence and death, yet interven...

Subject

Medicine

Breast cancer

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!